TreeWAS – Variant ID: rs114646238

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C15.5 Lower third of oesophagus	0.070	0.930	0.000
N30.8 Other cystitis	0.000	0.933	0.067
N30 Cystitis	0.000	0.943	0.057
N30.3 Trigonitis	0.000	0.948	0.052
N30.9 Cystitis, unspecified	0.000	0.951	0.049
N30.2 Other chronic cystitis	0.000	0.953	0.047
C15 Malignant neoplasm of oesophagus	0.045	0.955	0.000
N30.1 Interstitial cystitis (chronic)	0.000	0.956	0.044
N30.4 Irradiation cystitis	0.000	0.960	0.039
C15.9 Oesophagus, unspecified	0.039	0.961	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.000	0.965	0.035
C15.3 Upper third of oesophagus	0.034	0.966	0.000
C15.8 Overlapping lesion of oesophagus	0.032	0.967	0.000
C15.2 Abdominal part of oesophagus	0.032	0.967	0.000
C15.1 Thoracic part of oesophagus	0.032	0.967	0.000
C15.0 Cervical part of oesophagus	0.032	0.967	0.000
C15.4 Middle third of oesophagus	0.031	0.969	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.000	0.970	0.030
C85.1 B-cell lymphoma, unspecified	0.000	0.971	0.029
N30.0 Acute cystitis	0.000	0.972	0.027
C85.7 Other specified types of non-Hodgkin's lymphoma	0.000	0.976	0.024
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.000	0.978	0.022
C85.0 Lymphosarcoma	0.000	0.978	0.022
N18.3 Chronic kidney disease, stage 3	0.000	0.985	0.015
N18 Chronic renal failure	0.000	0.985	0.015
N18.9 Chronic renal failure, unspecified	0.000	0.986	0.014
N18.2 Chronic kidney disease, stage 2	0.000	0.987	0.013
N18.0 End-stage renal disease	0.000	0.987	0.013
O16 Unspecified maternal hypertension	0.012	0.988	0.000
N18.4 Chronic kidney disease, stage 4	0.000	0.988	0.012
L03.1 Cellulitis of other parts of limb	0.000	0.989	0.011
L03.2 Cellulitis of face	0.000	0.989	0.011
L03 Cellulitis	0.000	0.989	0.011
L03.0 Cellulitis of finger and toe	0.000	0.989	0.011
N18.8 Other chronic renal failure	0.000	0.989	0.011
N18.1 Chronic kidney disease, stage 1	0.000	0.989	0.011
N18.5 Chronic kidney disease, stage 5	0.000	0.989	0.011
K74.6 Other and unspecified cirrhosis of liver	0.000	0.990	0.010
M48.06 Spinal stenosis (Lumbar region)	0.010	0.990	0.000
O10-O16 Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium	0.010	0.990	0.000
O13 Gestational [pregnancy-induced] hypertension without significant proteinuria	0.009	0.991	0.000
L03.9 Cellulitis, unspecified	0.000	0.991	0.009
I27.0 Primary pulmonary hypertension	0.009	0.991	0.000
R52.2 Other chronic pain	0.008	0.992	0.000
I27 Other pulmonary heart diseases	0.008	0.992	0.000
O12 Gestational [pregnancy-induced] oedema and proteinuria without hypertension	0.008	0.992	0.000
O14 Gestational [pregnancy-induced] hypertension with significant proteinuria	0.008	0.992	0.000
O10 Pre-existing hypertension complicating pregnancy, childbirth and the puerperium	0.008	0.992	0.000
I27.9 Pulmonary heart disease, unspecified	0.008	0.992	0.000
M10.99 Gout, unspecified (Site unspecified)	0.000	0.993	0.007
R52.0 Acute pain	0.007	0.993	0.000
O15 Eclampsia	0.007	0.993	0.000
O11 Pre-existing hypertensive disorder with superimposed proteinuria	0.007	0.993	0.000
R52.9 Pain, unspecified	0.007	0.993	0.000
I27.2 Other secondary pulmonary hypertension	0.007	0.993	0.000
R52 Pain, not elsewhere classified	0.007	0.993	0.000
I42.0 Dilated cardiomyopathy	0.000	0.993	0.007
N30-N39 Other diseases of urinary system	0.000	0.993	0.007
N36 Other disorders of urethra	0.000	0.993	0.007
K31.8 Other specified diseases of stomach and duodenum	0.006	0.994	0.000
L03.8 Cellulitis of other sites	0.000	0.994	0.006
O14.1 Severe preeclampsia	0.006	0.994	0.000
C15-C26 Malignant neoplasms of digestive organs	0.006	0.994	0.000
O12.1 Gestational proteinuria	0.006	0.994	0.000
N36.0 Urethral fistula	0.000	0.994	0.006
O10.0 Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium	0.006	0.994	0.000
M19.91 Arthrosis, unspecified (Shoulder region)	0.006	0.994	0.000
I27.1 Kyphoscoliotic heart disease	0.006	0.994	0.000
O12.0 Gestational oedema	0.006	0.994	0.000
O12.2 Gestational oedema with proteinuria	0.006	0.994	0.000
N36.2 Urethral caruncle	0.000	0.994	0.006
O10.9 Unspecified pre-existing hypertension complicating pregnancy, childbirth and the puerperium	0.006	0.994	0.000
O10.4 Pre-existing secondary hypertension complicating pregnancy, childbirth and the puerperium	0.006	0.994	0.000
O10.3 Pre-existing hypertensive heart and renal disease complicating pregnancy, childbirth and the puerperium	0.006	0.994	0.000
O10.2 Pre-existing hypertensive renal disease complicating pregnancy, childbirth and the puerperium	0.006	0.994	0.000
O10.1 Pre-existing hypertensive heart disease complicating pregnancy, childbirth and the puerperium	0.006	0.994	0.000
O14.2 HELLP syndrome	0.006	0.994	0.000
O14.0 Moderate preeclampsia	0.006	0.994	0.000
O14.9 Preeclampsia, unspecified	0.006	0.994	0.000
L00-L08 Infections of the skin and subcutaneous tissue	0.000	0.994	0.006
O15.9 Eclampsia, unspecified as to time period	0.005	0.994	0.000
O15.2 Eclampsia in the puerperium	0.005	0.994	0.000
O15.1 Eclampsia in labour	0.005	0.994	0.000
O15.0 Eclampsia in pregnancy	0.005	0.994	0.000
L03.3 Cellulitis of trunk	0.000	0.995	0.005
N36.9 Urethral disorder, unspecified	0.000	0.995	0.005
I27.8 Other specified pulmonary heart diseases	0.005	0.995	0.000
C17 Malignant neoplasm of small intestine	0.005	0.995	0.000
N37 Urethral disorders in diseases classified elsewhere	0.000	0.995	0.005
N33 Bladder disorders in diseases classified elsewhere	0.000	0.995	0.005
L05 Pilonidal cyst	0.000	0.995	0.005
N34 Urethritis and urethral syndrome	0.000	0.995	0.005
I25.2 Old myocardial infarction	0.000	0.995	0.005
N32.9 Bladder disorder, unspecified	0.000	0.995	0.005
N36.3 Prolapsed urethral mucosa	0.000	0.995	0.005
N32 Other disorders of bladder	0.000	0.995	0.005
L05.9 Pilonidal cyst without abscess	0.000	0.995	0.005
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.005	0.995	0.000
C26 Malignant neoplasm of other and ill-defined digestive organs	0.005	0.995	0.000
N36.1 Urethral diverticulum	0.000	0.995	0.005
C16 Malignant neoplasm of stomach	0.005	0.995	0.000
M48.0 Spinal stenosis	0.005	0.995	0.000
C21 Malignant neoplasm of anus and anal canal	0.005	0.995	0.000
N36.8 Other specified disorders of urethra	0.000	0.995	0.005
C18 Malignant neoplasm of colon	0.005	0.995	0.000
C17.1 Jejunum	0.005	0.995	0.000
C23 Malignant neoplasm of gallbladder	0.004	0.995	0.000
L08 Other local infections of skin and subcutaneous tissue	0.000	0.995	0.005
M48.00 Spinal stenosis (Multiple sites in spine)	0.004	0.995	0.000
K40.3 Unilateral or unspecified inguinal hernia, with obstruction, without gangrene	0.005	0.995	0.000
C17.2 Ileum	0.004	0.996	0.000
N32.1 Vesicointestinal fistula	0.000	0.996	0.004
C18.6 Descending colon	0.004	0.996	0.000
C18.2 Ascending colon	0.004	0.996	0.000
L04 Acute lymphadenitis	0.000	0.996	0.004
L01 Impetigo	0.000	0.996	0.004
L00 Staphylococcal scalded skin syndrome	0.000	0.996	0.004
C18.8 Overlapping lesion of colon	0.004	0.996	0.000
L08.8 Other specified local infections of skin and subcutaneous tissue	0.000	0.996	0.004
C17.9 Small intestine, unspecified	0.004	0.996	0.000
C17.8 Overlapping lesion of small intestine	0.004	0.996	0.000
C17.3 Meckel's diverticulum	0.004	0.996	0.000
L05.0 Pilonidal cyst with abscess	0.000	0.996	0.004
N33.8 Bladder disorders in other diseases classified elsewhere	0.000	0.996	0.004
N33.0 Tuberculous cystitis	0.000	0.996	0.004
N37.8 Other urethral disorders in diseases classified elsewhere	0.000	0.996	0.004
N37.0 Urethritis in diseases classified elsewhere	0.000	0.996	0.004
C24.1 Ampulla of Vater	0.004	0.996	0.000
N34.3 Urethral syndrome, unspecified	0.000	0.996	0.004
N34.1 Nonspecific urethritis	0.000	0.996	0.004
N34.0 Urethral abscess	0.000	0.996	0.004
C16.3 Pyloric antrum	0.004	0.996	0.000
C21.8 Overlapping lesion of rectum, anus and anal canal	0.004	0.996	0.000
N34.2 Other urethritis	0.000	0.996	0.004
C16.2 Body of stomach	0.004	0.996	0.000
C18.5 Splenic flexure	0.004	0.996	0.000
C26.0 Intestinal tract, part unspecified	0.004	0.996	0.000
N32.4 Rupture of bladder, nontraumatic	0.000	0.996	0.004
N32.2 Vesical fistula, not elsewhere classified	0.000	0.996	0.004
H40.9 Glaucoma, unspecified	0.000	0.996	0.004
C16.0 Cardia	0.004	0.996	0.000
C21.1 Anal canal	0.004	0.996	0.000
C24.9 Biliary tract, unspecified	0.004	0.996	0.000
C24.8 Overlapping lesion of biliary tract	0.004	0.996	0.000
C24.0 Extrahepatic bile duct	0.004	0.996	0.000
E11.9 Without complications	0.000	0.996	0.004
C26.9 Ill-defined sites within the digestive system	0.004	0.996	0.000
C26.8 Overlapping lesion of digestive system	0.004	0.996	0.000
C26.1 Spleen	0.004	0.996	0.000
C17.0 Duodenum	0.004	0.996	0.000
C16.8 Overlapping lesion of stomach	0.004	0.996	0.000
C16.6 Greater curvature of stomach, unspecified	0.004	0.996	0.000
C16.5 Lesser curvature of stomach, unspecified	0.004	0.996	0.000
C16.4 Pylorus	0.004	0.996	0.000
C16.1 Fundus of stomach	0.004	0.996	0.000
M48.08 Spinal stenosis (Sacral and sacrococcygeal region)	0.004	0.996	0.000
M48.05 Spinal stenosis (Thoracolumbar region)	0.004	0.996	0.000
M48.04 Spinal stenosis (Thoracic region)	0.004	0.996	0.000
M48.03 Spinal stenosis (Cervicothoracic region)	0.004	0.996	0.000
M48.01 Spinal stenosis (Occipito-atlanto-axial region)	0.004	0.996	0.000
C21.2 Cloacogenic zone	0.003	0.996	0.000
U51.1 Previously admitted to a psychiatric hospital of the provider	0.004	0.996	0.000
N32.0 Bladder-neck obstruction	0.000	0.996	0.004
R60.0 Localised oedema	0.000	0.996	0.004
C18.1 Appendix	0.004	0.996	0.000
M48.07 Spinal stenosis (Lumbosacral region)	0.003	0.996	0.000
C19 Malignant neoplasm of rectosigmoid junction	0.004	0.996	0.000
C18.3 Hepatic flexure	0.003	0.996	0.000
E11 Non-insulin-dependent diabetes mellitus	0.000	0.996	0.004
L08.1 Erythrasma	0.000	0.996	0.003
L08.0 Pyoderma	0.000	0.996	0.003
E11.6 With other specified complications	0.000	0.996	0.003
C20 Malignant neoplasm of rectum	0.004	0.996	0.000
U80 Agent resistant to penicillin and related antibiotics	0.003	0.996	0.000
M48.09 Spinal stenosis (Site unspecified)	0.003	0.997	0.000
U80.0 Penicillin resistant agent	0.003	0.997	0.000
L02.4 Cutaneous abscess, furuncle and carbuncle of limb	0.000	0.997	0.003
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.003	0.997	0.000
K74 Fibrosis and cirrhosis of liver	0.000	0.997	0.003
L01.1 Impetiginisation of other dermatoses	0.000	0.997	0.003
L01.0 Impetigo [any organism] [any site]	0.000	0.997	0.003
L04.9 Acute lymphadenitis, unspecified	0.000	0.997	0.003
L04.8 Acute lymphadenitis of other sites	0.000	0.997	0.003
L04.3 Acute lymphadenitis of lower limb	0.000	0.997	0.003
L04.2 Acute lymphadenitis of upper limb	0.000	0.997	0.003
L04.1 Acute lymphadenitis of trunk	0.000	0.997	0.003
L04.0 Acute lymphadenitis of face, head and neck	0.000	0.997	0.003
R52.1 Chronic intractable pain	0.003	0.997	0.000
U51 Admission status on psychiatric patients	0.003	0.997	0.000
E14.9 Without complications	0.000	0.997	0.003
Z94.8 Other transplanted organ and tissue status	0.003	0.997	0.000
C21.0 Anus, unspecified	0.003	0.997	0.000
M10.9 Gout, unspecified	0.000	0.997	0.003
N31 Neuromuscular dysfunction of bladder, not elsewhere classified	0.000	0.997	0.003
H60.9 Otitis externa, unspecified	0.003	0.997	0.000
U80.1 Methicillin resistant agent	0.003	0.997	0.000
E14 Unspecified diabetes mellitus	0.000	0.997	0.003
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.000	0.997	0.003
E11.5 With peripheral circulatory complications	0.000	0.997	0.003
E11.2 With renal complications	0.000	0.997	0.003
C16.9 Stomach, unspecified	0.003	0.997	0.000
L90.5 Scar conditions and fibrosis of skin	0.000	0.997	0.003
N85.0 Endometrial glandular hyperplasia	0.003	0.997	0.000
I42 Cardiomyopathy	0.000	0.997	0.003
K74.0 Hepatic fibrosis	0.000	0.997	0.003
C25 Malignant neoplasm of pancreas	0.003	0.997	0.000
H40.2 Primary angle-closure glaucoma	0.000	0.997	0.003
U80.8 Agent resistant to other penicillin-related antibiotic	0.003	0.997	0.000
C18.4 Transverse colon	0.003	0.997	0.000
C91.1 Chronic lymphocytic leukaemia	0.000	0.997	0.003
M10.96 Gout, unspecified (Lower leg)	0.000	0.997	0.003
C91 Lymphoid leukaemia	0.000	0.997	0.003
H40 Glaucoma	0.000	0.997	0.003
L08.9 Local infection of skin and subcutaneous tissue, unspecified	0.000	0.997	0.003
E10.4 With neurological complications	0.000	0.997	0.003
L02 Cutaneous abscess, furuncle and carbuncle	0.000	0.997	0.003
U51.0 Not Previously admitted to a psyciatric hospital	0.003	0.997	0.000
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.003	0.997	0.000
M25.57 Pain in joint (Ankle and foot)	0.000	0.997	0.003
E11.8 With unspecified complications	0.000	0.997	0.003
E11.0 With coma	0.000	0.997	0.003
E10-E14 Diabetes mellitus	0.000	0.997	0.003
C18.9 Colon, unspecified	0.003	0.997	0.000
N35 Urethral stricture	0.000	0.997	0.003
E14.3 With ophthalmic complications	0.000	0.997	0.003
E11.7 With multiple complications	0.000	0.997	0.003
I67.2 Cerebral atherosclerosis	0.003	0.997	0.000
D23.7 Skin of lower limb, including hip	0.000	0.997	0.003
C22.7 Other specified carcinomas of liver	0.002	0.997	0.000
C22.4 Other sarcomas of liver	0.002	0.997	0.000
C22.3 Angiosarcoma of liver	0.002	0.997	0.000
C22.2 Hepatoblastoma	0.002	0.997	0.000
I42.6 Alcoholic cardiomyopathy	0.000	0.997	0.003
I42.1 Obstructive hypertrophic cardiomyopathy	0.000	0.997	0.003
K74.4 Secondary biliary cirrhosis	0.000	0.997	0.003
K74.2 Hepatic fibrosis with hepatic sclerosis	0.000	0.997	0.003
K74.1 Hepatic sclerosis	0.000	0.997	0.003
U51.2 Previously admitted to a psychiatric hospital of another provider	0.003	0.997	0.000
E11.4 With neurological complications	0.000	0.997	0.003
I42.9 Cardiomyopathy, unspecified	0.000	0.997	0.003
E10 Insulin-dependent diabetes mellitus	0.000	0.997	0.003
M10.98 Gout, unspecified (Other)	0.000	0.997	0.002
M10.95 Gout, unspecified (Pelvic region and thigh)	0.000	0.997	0.002
M10.92 Gout, unspecified (Upper arm)	0.000	0.997	0.002
M10.91 Gout, unspecified (Shoulder region)	0.000	0.997	0.002
N31.1 Reflex neuropathic bladder, not elsewhere classified	0.000	0.997	0.002
N31.0 Uninhibited neuropathic bladder, not elsewhere classified	0.000	0.997	0.002
N32.3 Diverticulum of bladder	0.000	0.997	0.003
E10.3 With ophthalmic complications	0.000	0.997	0.003
E14.8 With unspecified complications	0.000	0.997	0.002
E14.7 With multiple complications	0.000	0.997	0.002
E14.6 With other specified complications	0.000	0.997	0.002
E14.5 With peripheral circulatory complications	0.000	0.997	0.002
E14.4 With neurological complications	0.000	0.997	0.002
E14.2 Withrenal complications	0.000	0.997	0.002
E14.1 With ketoacidosis	0.000	0.997	0.002
E14.0 With coma	0.000	0.997	0.002
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.997	0.002
C94 Other leukaemias of specified cell type	0.000	0.997	0.002
C93 Monocytic leukaemia	0.000	0.997	0.002
C86 Other specified types of T/NK-cell lymphoma	0.000	0.997	0.002
C92 Myeloid leukaemia	0.000	0.997	0.002
M10.94 Gout, unspecified (Hand)	0.000	0.997	0.002
C88 Malignant immunoproliferative diseases	0.000	0.997	0.002
H40.8 Other glaucoma	0.000	0.997	0.002
I42.7 Cardiomyopathy due to drugs and other external agents	0.000	0.997	0.002
I42.5 Other restrictive cardiomyopathy	0.000	0.997	0.002
I42.4 Endocardial fibroelastosis	0.000	0.997	0.002
I42.3 Endomyocardial (eosinophilic) disease	0.000	0.997	0.002
C25.8 Overlapping lesion of pancreas	0.002	0.997	0.000
C25.7 Other parts of pancreas	0.002	0.997	0.000
C25.4 Endocrine pancreas	0.002	0.997	0.000
C25.3 Pancreatic duct	0.002	0.997	0.000
C25.2 Tail of pancreas	0.002	0.997	0.000
C25.1 Body of pancreas	0.002	0.997	0.000
D23 Other benign neoplasms of skin	0.000	0.997	0.003
C22.9 Liver, unspecified	0.002	0.998	0.000
D23.5 Skin of trunk	0.000	0.998	0.002
D23.6 Skin of upper limb, including shoulder	0.000	0.998	0.002
D23.0 Skin of lip	0.000	0.998	0.002
M48 Other spondylopathies	0.002	0.998	0.000
C91.9 Lymphoid leukaemia, unspecified	0.000	0.998	0.002
C91.8 Mature B-cell leukaemia Burkitt-type	0.000	0.998	0.002
C91.7 Other lymphoid leukaemia	0.000	0.998	0.002
C91.6 Prolymphocytic leukaemia of T-cell type	0.000	0.998	0.002
C91.5 Adult T-cell leukaemia	0.000	0.998	0.002
C91.4 Hairy-cell leukaemia	0.000	0.998	0.002
C91.3 Prolymphocytic leukaemia	0.000	0.998	0.002
C91.2 Subacute lymphocytic leukaemia	0.000	0.998	0.002
D23.1 Skin of eyelid, including canthus	0.000	0.998	0.002
I49.9 Cardiac arrhythmia, unspecified	0.002	0.998	0.000
I26-I28 Pulmonary heart disease and diseases of pulmonary circulation	0.002	0.998	0.000
H40.6 Glaucoma secondary to drugs	0.000	0.998	0.002
H40.4 Glaucoma secondary to eye inflammation	0.000	0.998	0.002
M10.93 Gout, unspecified (Forearm)	0.000	0.998	0.002
C22.0 Liver cell carcinoma	0.002	0.998	0.000
H40.1 Primary open-angle glaucoma	0.000	0.998	0.002
I25.9 Chronic ischaemic heart disease, unspecified	0.000	0.998	0.002
L02.8 Cutaneous abscess, furuncle and carbuncle of other sites	0.000	0.998	0.002
N31.2 Flaccid neuropathic bladder, not elsewhere classified	0.000	0.998	0.002
U50 Level of care administered to neonates	0.002	0.998	0.000
U07 Emergency use of U07	0.002	0.998	0.000
U06 Emergency use of U06	0.002	0.998	0.000
U04 Severe acute respiratory syndrome [SARS]	0.002	0.998	0.000
U52 First in a series of a regular day/night admissions	0.002	0.998	0.000
D23.9 Skin, unspecified	0.000	0.998	0.002
H40.0 Glaucoma suspect	0.000	0.998	0.002
H60 Otitis externa	0.002	0.998	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.000	0.998	0.002
E12 Malnutrition-related diabetes mellitus	0.000	0.998	0.002
C18.0 Caecum	0.002	0.998	0.000
N35.1 Postinfective urethral stricture, not elsewhere classified	0.000	0.998	0.002
N35.0 Posttraumatic urethral stricture	0.000	0.998	0.002
E10.5 With peripheral circulatory complications	0.000	0.998	0.002
C95 Leukaemia of unspecified cell type	0.000	0.998	0.002
K05.1 Chronic gingivitis	0.002	0.998	0.000
C92.1 Chronic myeloid leukaemia	0.000	0.998	0.002
I42.8 Other cardiomyopathies	0.000	0.998	0.002
C91.0 Acute lymphoblastic leukaemia	0.000	0.998	0.002
M10.90 Gout, unspecified (Multiple sites)	0.000	0.998	0.002
D23.2 Skin of ear and external auricular canal	0.000	0.998	0.002
E11.1 With ketoacidosis	0.000	0.998	0.002
H40.5 Glaucoma secondary to other eye disorders	0.000	0.998	0.002
H60.0 Abscess of external ear	0.002	0.998	0.000
U81 Agent resistant to vancomycin and related antibiotics	0.002	0.998	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.000	0.998	0.002
C81 Hodgkin's disease	0.000	0.998	0.002
E10.2 With renal complications	0.000	0.998	0.002
E13 Other specified diabetes mellitus	0.000	0.998	0.002
E10.7 With multiple complications	0.000	0.998	0.002
E10.0 With coma	0.000	0.998	0.002
N35.8 Other urethral stricture	0.000	0.998	0.002
H40.3 Glaucoma secondary to eye trauma	0.000	0.998	0.002
L02.9 Cutaneous abscess, furuncle and carbuncle, unspecified	0.000	0.998	0.002
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.000	0.998	0.002
C86.5 Angioimmunoblastic T-cell lymphoma	0.000	0.998	0.002
C86.4 Blastic NK-cell lymphoma	0.000	0.998	0.002
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.000	0.998	0.002
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.000	0.998	0.002
C86.1 Hepatosplenic T-cell lymphoma	0.000	0.998	0.002
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.000	0.998	0.002
C93.9 Monocytic leukaemia, unspecified	0.000	0.998	0.002
C93.7 Other monocytic leukaemia	0.000	0.998	0.002
C93.3 Juvenile myelomonocytic leukaemia	0.000	0.998	0.002
C93.2 Subacute monocytic leukaemia	0.000	0.998	0.002
C93.1 Chronic monocytic leukaemia	0.000	0.998	0.002
C93.0 Acute monocytic leukaemia	0.000	0.998	0.002
C94.7 Other specified leukaemias	0.000	0.998	0.002
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.000	0.998	0.002
C94.5 Acute myelofibrosis	0.000	0.998	0.002
C94.4 Acute panmyelosis	0.000	0.998	0.002
C94.3 Mast cell leukaemia	0.000	0.998	0.002
C94.2 Acute megakaryoblastic leukaemia	0.000	0.998	0.002
C94.1 Chronic erythraemia	0.000	0.998	0.002
C94.0 Acute erythraemia and erythroleukaemia	0.000	0.998	0.002
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.000	0.998	0.002
C96.8 Histiocytic sarcoma	0.000	0.998	0.002
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.998	0.002
C96.6 Unifocal Langerhans-cell histiocytosis	0.000	0.998	0.002
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.000	0.998	0.002
C96.4 Sarcoma of dendritic cells (accessory cells)	0.000	0.998	0.002
C96.3 True histiocytic lymphoma	0.000	0.998	0.002
C96.2 Malignant mast cell tumour	0.000	0.998	0.002
C96.1 Malignant histiocytosis	0.000	0.998	0.002
C96.0 Letterer-Siwe disease	0.000	0.998	0.002
K74.3 Primary biliary cirrhosis	0.000	0.998	0.002
L02.0 Cutaneous abscess, furuncle and carbuncle of face	0.001	0.998	0.002
C22.1 Intrahepatic bile duct carcinoma	0.002	0.998	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.000	0.998	0.002
C88.7 Other malignant immunoproliferative diseases	0.000	0.998	0.002
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.000	0.998	0.002
C88.3 Immunoproliferative small intestinal disease	0.000	0.998	0.002
C88.2 Gamma heavy chain disease	0.000	0.998	0.002
C88.1 Alpha heavy chain disease	0.000	0.998	0.002
C92.9 Myeloid leukaemia, unspecified	0.000	0.998	0.002
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.000	0.998	0.002
C92.7 Other myeloid leukaemia	0.000	0.998	0.002
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.000	0.998	0.002
C92.5 Acute myelomonocytic leukaemia	0.000	0.998	0.002
C92.4 Acute promyelocytic leukaemia	0.000	0.998	0.002
C92.3 Myeloid sarcoma	0.000	0.998	0.002
C92.2 Subacute myeloid leukaemia	0.000	0.998	0.002
K13.7 Other and unspecified lesions of oral mucosa	0.002	0.998	0.000
L02.1 Cutaneous abscess, furuncle and carbuncle of neck	0.000	0.998	0.002
E10.6 With other specified complications	0.000	0.998	0.002
H60.1 Cellulitis of external ear	0.002	0.998	0.000
K74.5 Biliary cirrhosis, unspecified	0.000	0.998	0.002
N31.8 Other neuromuscular dysfunction of bladder	0.000	0.998	0.002
M48.9 Spondylopathy, unspecified	0.002	0.998	0.000
M48.8 Other specified spondylopathies	0.002	0.998	0.000
M48.4 Fatigue fracture of vertebra	0.002	0.998	0.000
M48.3 Traumatic spondylopathy	0.002	0.998	0.000
M48.2 Kissing spine	0.002	0.998	0.000
M48.1 Ankylosing hyperostosis [Forestier]	0.002	0.998	0.000
H60.8 Other otitis externa	0.002	0.998	0.000
I28 Other diseases of pulmonary vessels	0.002	0.998	0.000
N17-N19 Renal failure	0.000	0.998	0.002
M10.97 Gout, unspecified (Ankle and foot)	0.000	0.998	0.002
M48.02 Spinal stenosis (Cervical region)	0.001	0.998	0.001
C88.0 Waldenstrom's macroglobulinaemia	0.000	0.998	0.002
I42.2 Other hypertrophic cardiomyopathy	0.000	0.998	0.002
H60.5 Acute otitis externa, non-infective	0.002	0.998	0.000
H60.4 Cholesteatoma of external ear	0.002	0.998	0.000
H60.3 Other infective otitis externa	0.002	0.998	0.000
H60.2 Malignant otitis externa	0.002	0.998	0.000
U04.9 Severe acute respiratory syndrome [SARS], unspecified	0.002	0.998	0.000
U06.9 Emergency use of U06.9	0.002	0.998	0.000
U06.8 Emergency use of U06.8	0.002	0.998	0.000
U06.7 Emergency use of U06.7	0.002	0.998	0.000
U06.6 Emergency use of U06.6	0.002	0.998	0.000
U06.5 Emergency use of U06.5	0.002	0.998	0.000
U06.4 Emergency use of U06.4	0.002	0.998	0.000
U06.3 Emergency use of U06.3	0.002	0.998	0.000
U06.2 Emergency use of U06.2	0.002	0.998	0.000
U06.1 Emergency use of U06.1	0.002	0.998	0.000
U06.0 Emergency use of U06.0	0.002	0.998	0.000
U07.9 Emergency use of U07.9	0.002	0.998	0.000
U07.8 Emergency use of U07.8	0.002	0.998	0.000
U07.7 Emergency use of U07.7	0.002	0.998	0.000
U07.6 Emergency use of U07.6	0.002	0.998	0.000
U07.5 Emergency use of U07.5	0.002	0.998	0.000
U07.4 Emergency use of U07.4	0.002	0.998	0.000
U07.3 Emergency use of U07.3	0.002	0.998	0.000
U07.2 Emergency use of U07.2	0.002	0.998	0.000
U07.1 Emergency use of U07.1	0.002	0.998	0.000
U07.0 Emergency use of U07.0	0.002	0.998	0.000
U50.9 Inquest Adjourned Death	0.002	0.998	0.000
U50.3 Level of care administered to neonates (Maximal Intensive Care)	0.002	0.998	0.000
U50.2 Level of care administered to neonates (High Dependancy Intensive Care)	0.002	0.998	0.000
U50.1 Level of care administered to neonates (Special Care)	0.002	0.998	0.000
U50.0 Level of care administered to neonates (Normal Care)	0.002	0.998	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.000	0.998	0.002
C84.8 Cutaneous T-cell lymphoma, unspecified	0.000	0.998	0.002
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.000	0.998	0.002
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.000	0.998	0.002
C84.4 Peripheral T-cell lymphoma	0.000	0.998	0.002
C84.3 Lymphoepithelioid lymphoma	0.000	0.998	0.002
C84.2 T-zone lymphoma	0.000	0.998	0.002
C84.1 Sezary's diease	0.000	0.998	0.002
C84.0 Mycosis fungoides	0.000	0.998	0.002
E12.9 Without complications	0.000	0.998	0.002
E12.8 With unspecified complications	0.000	0.998	0.002
E12.7 With multiple complications	0.000	0.998	0.002
E12.6 With other specified complications	0.000	0.998	0.002
E12.5 With peripheral circulatory complications	0.000	0.998	0.002
E12.4 With neurological complications	0.000	0.998	0.002
E12.3 With ophthalmic complications	0.000	0.998	0.002
E12.2 With renal complications	0.000	0.998	0.002
E12.1 With ketoacidosis	0.000	0.998	0.002
E12.0 With coma	0.000	0.998	0.002
M48.5 Collapsed vertebra, not elsewhere classified	0.002	0.998	0.000
C95.7 Other leukaemia of unspecified cell type	0.000	0.998	0.002
C95.2 Subacute leukaemia of unspecified cell type	0.000	0.998	0.002
C95.1 Chronic leukaemia of unspecified cell type	0.000	0.998	0.002
C95.0 Acute leukaemia of unspecified cell type	0.000	0.998	0.002
E87.2 Acidosis	0.000	0.998	0.002
I69.0 Sequelae of subarachnoid haemorrhage	0.002	0.998	0.000
G59.0 Diabetic mononeuropathy	0.000	0.998	0.002
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.000	0.998	0.002
E10.8 With unspecified complications	0.000	0.998	0.002
I67.1 Cerebral aneurysm, nonruptured	0.002	0.998	0.000
N83.2 Other and unspecified ovarian cysts	0.002	0.998	0.000
I67 Other cerebrovascular diseases	0.002	0.998	0.000
S92.30 Fracture of metatarsal bone (closed)	0.002	0.998	0.000
U81.8 Agent resistant to other vancomycin-related antibiotic	0.002	0.998	0.000
C25.0 Head of pancreas	0.002	0.998	0.000
C81.7 Other Hodgkin's disease	0.000	0.998	0.002
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.000	0.998	0.002
C81.3 Lymphocytic depletion	0.000	0.998	0.002
C81.2 Mixed cellularity	0.000	0.998	0.002
C81.1 Nodular sclerosis	0.000	0.998	0.002
C81.0 Lymphocytic predominance	0.000	0.998	0.002
C82.6 Cutaneous follicle centre lymphoma	0.000	0.998	0.002
C82.5 Diffuse follicle centre lymphoma	0.000	0.998	0.002
C82.4 Follicular lymphoma grade IIIb	0.000	0.998	0.002
C82.3 Follicular lymphoma grade IIIa	0.000	0.998	0.002
E13.8 With unspecified complications	0.000	0.998	0.002
E13.7 With multiple complications	0.000	0.998	0.002
E13.6 With other specified complications	0.000	0.998	0.002
E13.5 With peripheral circulatory complications	0.000	0.998	0.002
E13.4 With neurological complications	0.000	0.998	0.002
E13.3 With ophthalmic complications	0.000	0.998	0.002
E13.2 With renal complications	0.000	0.998	0.002
E13.1 With ketoacidosis	0.000	0.998	0.002
E13.0 With coma	0.000	0.998	0.002
Z99.8 Dependence on other enabling machines and devices	0.000	0.998	0.002
M90.71 Fracture of bone in neoplastic disease (Shoulder region)	0.002	0.998	0.000
C18.7 Sigmoid colon	0.002	0.998	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.000	0.998	0.002
K05.6 Periodontal disease, unspecified	0.002	0.998	0.000
Z91.0 Personal history of allergy, other than to drugs and biological substances	0.000	0.998	0.002
L90 Atrophic disorders of skin	0.000	0.998	0.002
C25.9 Pancreas, unspecified	0.002	0.998	0.000
C82.0 Small cleaved cell, follicular	0.000	0.998	0.002
M90.78 Fracture of bone in neoplastic disease (Other)	0.002	0.998	0.000
C92.0 Acute myeloid leukaemia	0.000	0.998	0.002
N31.9 Neuromuscular dysfunction of bladder, unspecified	0.000	0.998	0.002
U81.0 Vancomycin resistant agent	0.001	0.998	0.000
M48.19 Ankylosing hyperostosis [Forestier] (Site unspecified)	0.001	0.998	0.000
M48.18 Ankylosing hyperostosis [Forestier] (Sacral and sacrococcygeal region)	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations